Ulrike Winkler Jenks

Array ( [id] => 1331391 [patent_doc_number] => 06596497 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Screening of antiviral compounds targeted to the HIV-1 gp41 core structure' [patent_app_type] => B1 [patent_app_number] => 09/525874 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 16035 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596497.pdf [firstpage_image] =>[orig_patent_app_number] => 09525874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1271660 [patent_doc_number] => 06653447 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'ULBP DNA and polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/524100 [patent_app_country] => US [patent_app_date] => 2000-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31212 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653447.pdf [firstpage_image] =>[orig_patent_app_number] => 09524100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1080659 [patent_doc_number] => 06835715 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Mammalian dihydroouabain-like factor and therapeutic compositions' [patent_app_type] => B1 [patent_app_number] => 09/503559 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13223 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835715.pdf [firstpage_image] =>[orig_patent_app_number] => 09503559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355819 [patent_doc_number] => 06291652 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Antibodies specific for proteins having polyglutamine expansions' [patent_app_type] => 1 [patent_app_number] => 9/478960 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6522 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291652.pdf [firstpage_image] =>[orig_patent_app_number] => 478960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342770 [patent_doc_number] => 06582706 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS' [patent_app_type] => B1 [patent_app_number] => 09/468656 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 12441 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582706.pdf [firstpage_image] =>[orig_patent_app_number] => 09468656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413489 [patent_doc_number] => 06514501 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Recombinant vaccine against dengue virus' [patent_app_type] => B1 [patent_app_number] => 09/468517 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 8904 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514501.pdf [firstpage_image] =>[orig_patent_app_number] => 09468517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1422296 [patent_doc_number] => 06506893 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds' [patent_app_type] => B1 [patent_app_number] => 09/446301 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 18342 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506893.pdf [firstpage_image] =>[orig_patent_app_number] => 09446301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507074 [patent_doc_number] => 06440718 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Method for producing non-infectious recombinant picornavirus particles' [patent_app_type] => B1 [patent_app_number] => 09/381847 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 2434 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440718.pdf [firstpage_image] =>[orig_patent_app_number] => 09381847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4385313 [patent_doc_number] => 06277973 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Cloning and expression of a DNA sequence encoding a 41 kDa cryptosporidium parvum oocyst wall protein' [patent_app_type] => 1 [patent_app_number] => 9/451117 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13763 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277973.pdf [firstpage_image] =>[orig_patent_app_number] => 451117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435610 [patent_doc_number] => 06355252 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Soluble vaccinia virus protein that binds chemokines' [patent_app_type] => B1 [patent_app_number] => 09/367781 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10405 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355252.pdf [firstpage_image] =>[orig_patent_app_number] => 09367781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4423335 [patent_doc_number] => 06225454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Sialidase localized in plasma membrane and DNA coding for the same' [patent_app_type] => 1 [patent_app_number] => 9/423340 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6196 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225454.pdf [firstpage_image] =>[orig_patent_app_number] => 423340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533794 [patent_doc_number] => 06410713 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'DNA encoding proteins that inhibit Hsp70 function' [patent_app_type] => B1 [patent_app_number] => 09/444336 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10712 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410713.pdf [firstpage_image] =>[orig_patent_app_number] => 09444336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017636 [patent_doc_number] => 06890528 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Cells for the production of helper dependent adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 09/831182 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12778 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890528.pdf [firstpage_image] =>[orig_patent_app_number] => 09831182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527920 [patent_doc_number] => 06479280 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Recombinant phages capable of entering host cells via specific interaction with an artificial receptor' [patent_app_type] => B1 [patent_app_number] => 09/433404 [patent_app_country] => US [patent_app_date] => 1999-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9061 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479280.pdf [firstpage_image] =>[orig_patent_app_number] => 09433404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436142 [patent_doc_number] => 06355786 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same' [patent_app_type] => B1 [patent_app_number] => 09/430503 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 51363 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355786.pdf [firstpage_image] =>[orig_patent_app_number] => 09430503 [rel_patent_id] =>[rel_patent_doc_number] =>)